Cited by 359HER2/EGFR in Cancer ResearchProtein Kinase Regulation and GTPase SignalingLung Cancer Treatments and Mutations

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface

Open access

Zhang, Xuewu, Pickin, Kerry A., Bose, Ron, Jura, Natalia, Cole, Philip A., Kuriyan, John·2007·Nature

DOI 10.1038/nature05998PMC PMC3561764

Open this paper in CoChat — free account

Abstract

Members of the epidermal growth factor receptor family (EGFR/ERBB1, ERBB2/HER2, ERBB3/HER3 and ERBB4/HER4) are key targets for inhibition in cancer therapy. Critical for activation is the formation of an asymmetric dimer by the intracellular kinase domains, in which the carboxy-terminal lobe (C lobe) of one kinase domain induces an active conformation in the other. The cytoplasmic protein MIG6 (mitogen-induced gene 6; also known as ERRFI1) interacts with and inhibits the kinase domains of EGFR and ERBB2 (refs 3–5). Crystal structures of complexes between the EGFR kinase domain and a fragment of MIG6 show that a ∼25-residue epitope (segment 1) from MIG6 binds to the distal surface of the C lobe of the kinase domain. Biochemical and cell-based analyses confirm that this interaction contributes to EGFR inhibition by blocking the formation of the activating dimer interface. A longer MIG6 peptide that is extended C terminal to segment 1 has increased potency as an inhibitor of the activated EGFR kinase domain, while retaining a critical dependence on segment 1. We show that signalling by EGFR molecules that contain constitutively active kinase domains still requires formation of the asymmetric dimer, underscoring the importance of dimer interface blockage in MIG6-mediated inhibition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature05998

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1609 · Cited by 3,379
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Zhang, X., Gureasko, J., Shen, K., Cole, P. A., & Kuriyan, J. (2006) · Cell · doi:10.1016/j.cell.2006.05.013 · Cited by 1,650
Self-citation
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. E. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,605
Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor
Stamos, J. L., Sliwkowski, M. X., & Eigenbrot, C. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207135200 · Cited by 1,594
Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex
Jeffrey, P. D., Russo, A. A., Polyák, K., Gibbs, E., Hurwitz, J., Massagué, J., & Pavletich, N. P. (1995) · Nature · doi:10.1038/376313a0 · Cited by 1,455
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
Wood, E. R., Truesdale, A. T., McDonald, O. B., Yuan, D. Y., Hassell, A. M., Dickerson, S. H., Ellis, B., Pennisi, C., Horne, E., Lackey, K. E., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1168 · Cited by 1,125
Crystallographic analysis of the specific yet versatile recognition of distinct nuclear localization signals by karyopherin α
Conti, E., & Kuriyan, J. (2000) · Structure · doi:10.1016/s0969-2126(00)00107-6 · Cited by 310
Self-citation
Mig6 is a negative regulator of EGF receptor–mediated skin morphogenesis and tumor formation
Ferby, I., Reschke, M., Kudlacek, O., Knyazev, P. G., Panté, G., Amann, K., Sommergruber, W., Kraut, N., Ullrich, A., Fässler, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1401 · Cited by 259
EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation
Reynolds, A. R., Tischer, C., Verveer, P. J., Rocks, O., & Bastiaens, P. I. H. (2003) · Nature Cell Biology · doi:10.1038/ncb981 · Cited by 235

Flagged first, then by citations

Show all 22 references

Sorted by citations

Items 301–359 of 359

Mutation-Dependent Conformational Dynamics and Dual-Mode Afatinib Binding in EGFR Exon 19 Variants
Bhanja, K., Ghosh, R., & Patra, N. (2026) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6c03491 · Cited by 1
A disease annotation study of gene signatures in a breast cancer microarray dataset
Gypas, F., Bei, E. S., Zervakis, M., & Sfakianakis, S. G. (2011) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2011.6091416 · Cited by 1
Role of rho-family guanosine triphosphatase effectors in filopodia dynamics
De, A. (2015) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Monitoring Conformational Changes in the Receptor Tyrosine Kinase EGFR
Becker, C., Öcal, S., Nguyen, H. D., Phan, T. T. P., Keul, M., Simard, J. R., & Rauh, D. (2016) · ChemBioChem · doi:10.1002/cbic.201600115 · Cited by 1
Kinase Mutations and Resistance in Cancer
Bikker, J. A. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733557-00126 · Cited by 1
DEFINING THE ROLE OF EGFR ACETYLATION IN CELLULAR PROCESSES: CLINICAL IMPLICATIONS
Song, H. (2011) · Digital Commons-TMC (Texas Medical Center) · Cited by 1
A conserved dimerization element is required for protein kinase activation by trans -autophosphorylationPreprint
Botterbusch, S., Huso, V. L., Weingartner, K. A., Tryggvason, G., Tripp, K. W., Green, R., & Kavran, J. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.726961 · Cited by 1
SH Domains and Epidermal Growth Factor Receptors
Kurochkina, N. A., Guha, U., & Lu, Z. (2015) · Springer eBooks · doi:10.1007/978-3-319-20098-9_7
Experimental and Computational Analysis of Epidermal Growth Factor Receptor Pathway Phosphorylation Dynamics
Kleiman, L. B. (2010) · DSpace@MIT (Massachusetts Institute of Technology)
Global Gene Expression Program of Lysophosphatidic Acid (LPA)‐Stimulated Fibroblasts
Stortelers, C., & Moolenaar, W. H. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch3
Analysis of progesterone-regulated target genes in mammary gland and uterine development
Walsh, C. (2009) · Arrow - TU Dublin (Technological University Dublin) · doi:10.21427/d7x611
Identification and Functional Characterisation of Genes regulated by Monomeric Actin
Descot, A. (2010) · doi:10.5282/edoc.12578
ERBB4 mutations in cancer and amyotrophic lateral sclerosis
Kurppa, K. J. (2014) · UTUPub (University of Turku)
A Trigger Squeezed
Eigenbrot, C. W. (2008) · Structure · doi:10.1016/j.str.2008.02.002
A monkey wrench in the kinase machine
Leahy, D. J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1207-1120
Mig-6 and Its Role in Regulating Adult Lung Epithelium
Bennett, S. (2010) · Arrow - TU Dublin (Technological University Dublin) · doi:10.21427/d78p5g
Epidermal Growth Factor Receptor in Joint Health and Osteoarthritis
Pest, M. A. (2015) · Scholarship@Western (Western University)
Stress-inducible Mig6 promotes pancreatic beta cell destruction in the pathogenesis of diabetes
Chen, Y. (2014) · doi:10.7912/c2/2003
HER
Köstler, W. J., & Yarden, Y. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.011
Modulation of the Progenitor Cell and Homeostatic Capacities of Müller Glia Cells in Retina : Focus on α2-Adrenergic and Endothelin Receptor Signaling Systems
Harun‐Or‐Rashid, M. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Host epithelial responses to Neisserial colonisation
Wong, E. E. H. (2010) · doi:10.25560/6045
Stress-activated MIG6 compromises hepatic metabolism during diet-induced obesity
Lutkewitte, A. J. (2016) · IUScholarWorks (Indiana University) · doi:10.7912/c2w59n
Molecular design and engineering of phosphopeptide ligands to target lung cancer polo-like kinase
Yu, X., Li, Y., Lou, Y., & Wang, T. (2017) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-016-0441-9
Using Biochemical and Structural Approaches to Study EGFR-family Heterodimers
Raines, L. L. (2016)
Studies of the Allosteric Activation of the Epidermal Growth Factor Receptor
Engel, K. A. (2013) · eScholarship (California Digital Library)
Cyclization strategies to stabilize epidermal growth factor receptor dimerization arm mimics
Hanold, L. E. (2016)
Tumor Genetics and Their Outcomes on Surgery and Survival
Ehresman, J., & Bettegowda, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811783-5.00010-0
Mechanisms of epidermal growth factor receptor tyrosine kinase activation and nuclear trafficking
Brewer, M. R. (2009)
Mig6 decreases hepatic EGFR activation and survival during saturated fatty acid-induced endoplasmic reticulum stressPreprint
Lutkewitte, A. J., Chen, Y., Hansen, J. L., & Fueger, P. T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.24.380527
El tratamiento de aguas industriales contaminadas con sulfuros
Coira, M. V. R., Aguila, L. A., & Miguel, R. V. (2003) · Residuos: Revista técnica
Faculty Opinions recommendation of Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.
Buck, M. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1161731.624184
Faculty Opinions recommendation of Tyrosine phosphorylation controls brassinosteroid receptor activation by triggering membrane release of its kinase inhibitor.
Huber, S. C. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.8220965.8640069
Identification and Characterization of miR-148a as a New Oncogenic and Prognostic microRNA in Glioblastoma
Kim, J. (2014) · doi:10.18130/v3hn75
A growth-based platform for detecting domain–peptide interactions in the cytoplasm of mammalian cells
Kimura, Y., Kashima, D., & Kawahara, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-22770-4
Effect of Gene 33/Mig6/ERRFI1 on hexavalent chromium-induced transformation of human bronchial epithelial cells depends on the length of exposure
Li, C., Edeni, D., Platkin, S., Liu, R., Li, J., Hossain, M., Rahman, M., Islam, H. K., Phillips, J. L., & Xu, D. (2022) · Journal of Environmental Science and Health Part C · doi:10.1080/26896583.2022.2147358
Control of EGFR signaling by endocytosis and endosomal trafficking
Ghosh, C., Xing, Y., & Sun, Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822833-3.00014-0
Pancreatic loss of Mig6 alters murine endocrine cell fate and protects functional beta cell mass in an STZ-induced model of diabetesPreprint
Bauer, B. M., Irimia, J. M., Bloom‐Saldana, E., Jeong, J., & Fueger, P. T. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.07.536046 · Cited by 1
Role and Application of Biomolecules for Regeneration of Cartilage Tissue
Nakamichi, R., Fujii, Y., & Asahara, H. (2023) · Springer eBooks · doi:10.1007/978-981-99-2452-3_7
Precision oncology strategy in cetuximab-resistant ERRFI1-mutant colon cancer: case report of disease progression on afatinib.
Kuznetsova, O. A., Lebedeva, A., Kavun, A., Belova, E., Fedyanin, M. Y., Mileyko, V., Ivanov, M. V., & Nosov, D. (2023) · PubMed Central
EGFR and tyrosine kinase inhibitor interactions probed by hydrogen-deuterium exchange and mass spectrometry (HDX-MS)Preprint
Ashtekar, K. D., Lemmon, M. A., & Tsutsui, Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.14.618277
Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor
Hayashi, S. Y., Pak, S., Torlentino, A., Rizzo, R. C., & Miller, W. T. (2024) · The FASEB Journal · doi:10.1096/fj.202401330r
High MIG-6 expression promotes tumor proliferation and metastasis of gastric cancer
Zhao, W., Jin, T., Liu, Y., Shao, S., & Cui, F. (2025) · Journal of Cancer · doi:10.7150/jca.98431
Role and therapeutic potential of the NEDD4 family in breast cancer
Zhang, X., & Li, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1587675
Self-citation
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapy
Keddar, M. R., Pro, S. C., Rabbie, R., Atak, Z. K., Muyas, F., Stewart, A. C., Hammond, S. A., Palmer, D. C., Stewart, R. A., Carey, M., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-014321
Active regulation of the epidermal growth factor receptor by the membrane bilayerPreprint
Srinivasan, S., Lin, X., Chen, X., Regmi, R., Zhang, B., & Schlau‐Cohen, G. S. (2025) · eLife · doi:10.7554/elife.108789.1
Additional file 1 of Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
Kang, D. H., Jung, S. S., Yeo, M.-K., Lee, D. H., Yoo, G., Cho, S. Y., Oh, I.-J., Kim, J.-O., Park, H. S., Chung, C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12511226
Active regulation of the epidermal growth factor receptor by the membrane bilayerPreprint
Srinivasan, S., Lin, X., Chen, X., Regmi, R., Zhang, B., & Schlau‐Cohen, G. S. (2026) · eLife · doi:10.7554/elife.108789.2
Étude du rôle de la protéine de liaison aux ARN messagers Smaug dans la voie Hedgehog chez la drosophile
Argüelles, C. (2017) · theses.fr (ABES) · doi:10.70675/a4e93013z2a18z44f2za36bzc050bc632a48
Zerumbone Induced ROS ‐Mediated Autophagic Cell Death in Human Melanoma Cells: An In Vitro and In Vivo Study
Chen, S.-J., Hseu, Y., Zhang, Y., Pandey, S., Bhat, A. A., Li, Y., Huang, P.-J., Yang, H., & Hseu, J. (2026) · BioFactors · doi:10.1002/biof.70110
Invasion/metastasis-related differentially methylated genes predict prognosis in diffuse gliomas
Zhang, S., Sun, Z., Jiang, S., Meng, L., & Li, M. (2026) · Journal of Neuro-Oncology · doi:10.1007/s11060-026-05662-9
Osteoblast-derived CTGF contributes to detrimental bone-cartilage crosstalk via EGFR/ NF-κB signaling pathway in estrogen-deficiency-induced osteoarthritis
Yang, Z., Tan, Q., Li, S., Jiang, A., Zhong, Y., Chen, L., Hong, H., Li, Z., Song, C., Li, W., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.07.050
ACK family tyrosine kinases as potential therapeutic targets for cancer
Mittal, R., Priya, P., Banerjee, J., & Dixit, A. B. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2709794
Human iPSC-EV-loaded nanofiber stent coatings accelerate vascular repair by enhancing EGFR/HIF-1α signaling and suppressing ROCK1-mediated remodeling
Lee, C., Hsieh, M., Chen, D., Chu, L. J., Tsai, C.-L., Chang, K., Chen, Z.-Y., Hsieh, I.-C., Chu, P., Wen, M., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103564
Asymmetric dimerization and allosteric control in the epidermal growth factor receptor
Huang, Y., Eisen, T. J., Nair, A., Muratcioğlu, S., & Kuriyan, J. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2024.0502
Self-citation
HRD: an integrated multi-omics resource for human reproduction and development
Liu, C., Zhang, X., Lang, T., Feng, L., Liu, H., Yang, T., Xiang, M., Li, Y., Chen, X., Xie, T., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag1006
Self-citation
BindingDB Entry 50022808: Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy.
BindingDB (2026) · UC San Diego · doi:10.7270/q2bc44cm
BindingDB Entry 50028317: Kinase domain mutations in cancer: implications for small molecule drug design strategies.
杣田, 佳. (2010) · UC San Diego · doi:10.7270/q2br8s36
BindingDB Entry 50009263: Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases.
BindingDB (2021) · UC San Diego · doi:10.7270/q25x2dc4
BindingDB Entry 5651: Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.
BindingDB (2012) · UC San Diego · doi:10.7270/q27w69th

Authors: Zhang, X., Pickin, K. A., Bose, R., Jura, N., Cole, P. A., & Kuriyan, J.
Affiliations: Howard Hughes Medical Institute (US)
Johns Hopkins University (US)
Corresponding author: Kuriyan, John
ORCID: Zhang, Xuewu
Bose, Ron
Jura, Natalia
Cole, Philip A.
Kuriyan, John
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2007-11-29
Volume: 450
Issue: 7170
Pages: 741-744
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature05998
PMC: PMC3561764
OpenAlex: W2046151919
Semantic Scholar: 84bdab56e088c2422419e9cd91b3387be8d1ee60
Cited by: 357
References: 22
Citations by year: 2026: 17 · 2025: 8 · 2024: 6 · 2023: 13 · 2022: 13 · 2021: 13 · 2020: 16 · 2019: 10 · 2018: 15 · 2017: 20 · 2016: 33 · 2015: 31 · 2014: 37 · 2013: 18 · 2012: 20
FWCI: 10.09
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: Susan G. Komen for the Cure
Susan G. Komen
National Institutes of Health
National Cancer Institute (R01CA096504)
Topics: Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
Keywords: epidermal growth factor receptor, MIG6, ERBB2, HER2, allosteric inhibition, EGFR signaling, constitutively active kinase, product inhibition
MeSH terms: Animals, Binding Sites, Chlorocebus aethiops, Humans, Models, Biological, Models, Molecular, Phosphorylation, Protein Binding, Protein Structure, Tertiary, Crystallography, X-Ray, Dimerization, COS Cells, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks